Exercise Can Shrink Belly Fat, But Not When Drug Blocks IL-6 Exercise Can Shrink Belly Fat, But Not When Drug Blocks IL-6
Exercise reduced abdominal visceral fat, a risk factor for cardiometabolic disease, but not when obese patients received tocilizumab, an anti-arthritis drug that blocks IL-6 receptors, in a new study.Medscape Medical News
Source: Medscape Diabetes Headlines - Category: Endocrinology Tags: Diabetes & Endocrinology News Source Type: news
More News: Actemra | Arthritis | Cardiology | Diabetes | Eating Disorders & Weight Management | Endocrinology | Heart | Obesity | Rheumatology | Sports Medicine | Study